{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:25Z","timestamp":1792181725753,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00065"],"award-info":[{"award-number":["75N93019C00065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["EMCLSH19012"],"award-info":[{"award-number":["EMCLSH19012"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.09.022","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:20:25Z","timestamp":1694992825000},"page":"6495-6504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-0646","authenticated-orcid":false,"given":"Katharina S.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouskha D.","family":"Comvalius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nella J.","family":"Nieuwkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-0761","authenticated-orcid":false,"given":"Daryl","family":"Geers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ramsauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4999-7070","authenticated-orcid":false,"given":"Roland","family":"Tschismarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik L.","family":"de Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.09.022_b0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3201\/eid2104.141723","article-title":"Reappearance of chikungunya, formerly called dengue, in the Americas","volume":"21","author":"Halstead","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.06.009","article-title":"Prediction and prevention of urban arbovirus epidemics: a challenge for the global virology community","volume":"156","author":"Weaver","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2023.09.022_b0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Campion","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.09.022_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006919","article-title":"Chikungunya as a paradigm for emerging viral diseases: evaluating disease impact and hurdles to vaccine development","volume":"13","author":"Rezza","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/srep23997","article-title":"Evaluating the effectiveness of localized control strategies to curtail chikungunya","volume":"6","author":"Ndeffo-Mbah","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.09.022_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003764","article-title":"High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines","volume":"9","author":"Yoon","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijid.2020.03.073","article-title":"Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort","volume":"95","author":"Yoon","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0040","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3201\/eid2210.160729","article-title":"Resolution of a chikungunya outbreak in a prospective cohort, Cebu, Philippines, 2012\u20132014","volume":"22","author":"Srikiatkhachorn","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0045","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.2147\/DDDT.S366112","article-title":"Chikungunya vaccine candidates: current landscape and future prospects","volume":"16","author":"Schmidt","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.vaccine.2023.09.022_b0050","unstructured":"WHO. Measles fact sheet; 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles?gclid=CjwKCAjwwL6aBhBlEiwADycBIEuGnWquH0gaTaPBRu4pT5Y9MjPpGrxk1uDEvsEhXg0t59FwhaRgsBoChLAQAvD_BwE."},{"key":"10.1016\/j.vaccine.2023.09.022_b0055","unstructured":"CDC. Measles vaccination; 2021. https:\/\/www.cdc.gov\/vaccines\/vpd\/measles\/index.html."},{"key":"10.1016\/j.vaccine.2023.09.022_b0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0264-410X(99)00396-5","article-title":"Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination","volume":"18","author":"Bautista-L\u00f3pez","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.022_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41541-022-00543-4","article-title":"Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines","volume":"7","author":"Ebenig","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.09.022_b0070","first-page":"1678","article-title":"The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection","volume":"12","author":"Hu","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.09.022_b0075","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","article-title":"A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus","volume":"31","author":"Brandler","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.022_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.09.022_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41541-023-00643-9","article-title":"A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9","volume":"8","author":"H\u00f6rner","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.09.022_b0090","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz202","article-title":"Immunogenicity and efficacy of a measles virus-vectored chikungunya vaccine in nonhuman primates","author":"Rossi","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0095","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","author":"Reisinger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.09.022_b0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151095","article-title":"Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine","volume":"6","author":"Tschismarov","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2023.09.022_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A Sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2023.09.022_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/763461","article-title":"Automatic generation of validated specific epitope sets","volume":"2015","author":"Carrasco Pro","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2023.09.022_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2023.09.022_b0125","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2023.09.022_b0130","article-title":"update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2023.09.022_b0135","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jaci.2015.01.039","article-title":"Control of immunopathology during chikungunya virus infection","volume":"135","author":"Petitdemange","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2023.09.022_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003354","article-title":"Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection","volume":"8","author":"Poo","year":"2014","journal-title":"PLOS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jiq006","article-title":"The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation","volume":"204","author":"Wauquier","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171989","article-title":"The neutralizing role of IgM during early chikungunya virus infection","volume":"12","author":"Chua","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.09.022_b0155","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.09.022_b0160","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s10096-017-3087-4","article-title":"Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study","volume":"36","author":"Kulkarni","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084695","article-title":"Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005\u20132006 in La Reunion Island","volume":"8","author":"Hoarau","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2023.09.022_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00104-16","article-title":"Vaccine and therapeutic options to control chikungunya virus","volume":"31","author":"Powers","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2023.09.022_b0175","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virusres.2012.05.004","article-title":"Subunit vaccine formulations based on recombinant envelope proteins of chikungunya virus elicit balanced Th1\/Th2 response and virus-neutralizing antibodies in mice","volume":"167","author":"Khan","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.09.022_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002970","article-title":"A novel MVA vectored chikungunya virus vaccine elicits protective immunity in mice","volume":"8","author":"Weger-Lucarelli","year":"2014","journal-title":"PLOS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/vim.2012.0061","article-title":"Nonstructural protein 2 (nsP2) of chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA vaccine","volume":"26","author":"Bao","year":"2013","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2023.09.022_b0190","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.022_b0195","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.09.022_b0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.09.022_b0205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.83527","article-title":"Attenuated and vectored vaccines protect nonhuman primates against chikungunya virus","volume":"2","author":"Roques","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2023.09.022_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24906-y","article-title":"A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial","volume":"12","author":"Folegatti","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.09.022_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035515","article-title":"In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns","volume":"13","author":"Lopes-Ribeiro","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.09.022_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006036","article-title":"Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein","volume":"11","author":"Lorente","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007547","article-title":"Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence","volume":"13","author":"Lorente","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2023.09.022_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24820-2","article-title":"Effects of pre-existing orthopoxvirus-specific immunity on the performance of modified vaccinia virus Ankara-based influenza vaccines","volume":"8","author":"Altenburg","year":"2018","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:23Z","timestamp":1759404623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23010927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":47,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X23010927"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}